Harvard Apparatus Regenerative Technology Inc. (HRGN)

OTCMKTS · Delayed Price · Currency is USD

1.572

0.00 (0.00%)

Apr 13, 2026, 9:30 AM EST

Revenue by Segment

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Consumer Health Products	704.00K	430.00K	103.00K	-						-
Consumer Health Products Growth	63.72%	317.48%	-	-						-
Development and Commercialization of Regenerated Organs for Human Transplant	-	-	-	-						82.00K
Development and Commercialization of Regenerated Organs for Human Transplant Growth	-	-	-	-						-30.51%
Total	704.00K	430.00K	103.00K	-						82.00K
Total Growth	63.72%	317.48%	-	-						-30.51%

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States	704.00K	430.00K	103.00K	-						82.00K
United States Growth	63.72%	317.48%	-	-						-30.51%
Total	704.00K	430.00K	103.00K	-						82.00K
Total Growth	63.72%	317.48%	-	-						-30.51%

Source: S&P Global Market Intelligence.